The 31-gene expression profile stratifies recurrence and metastasis risk in patients with cutaneous melanoma.
Saved in:
| Title: | The 31-gene expression profile stratifies recurrence and metastasis risk in patients with cutaneous melanoma. |
|---|---|
| Authors: | Jarell A; Northeast Dermatology Associates, PC, Portsmouth, NH 03801, USA., Skenderis B; Coastal Surgical Specialists, PC, Virginia Beach, VA 23455, USA., Dillon LD; Surgical Oncology & General Surgery, Colorado Springs, CO 80907, USA., Dillon K; Surgical Oncology & General Surgery, Colorado Springs, CO 80907, USA., Martin B; Castle Biosciences, Inc. Friendswood, TX 77546, USA., Quick AP; Castle Biosciences, Inc. Friendswood, TX 77546, USA., Siegel JJ; Castle Biosciences, Inc. Friendswood, TX 77546, USA., Rackley BB; Castle Biosciences, Inc. Friendswood, TX 77546, USA., Cook RW; Castle Biosciences, Inc. Friendswood, TX 77546, USA. |
| Source: | Future oncology (London, England) [Future Oncol] 2021 Dec; Vol. 17 (36), pp. 5023-5031. Date of Electronic Publication: 2021 Sep 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-8301 |
|---|---|
| DOI: | 10.2217/fon-2021-0996 |
